Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/27/2002WO2002103002A2 Gene associated with leishmania parasite virulence
12/27/2002WO2002102999A1 Attenuated circovirus
12/27/2002WO2002102998A1 Animal with gene hypoexpression
12/27/2002WO2002102997A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/27/2002WO2002102996A1 Male contraceptives
12/27/2002WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same
12/27/2002WO2002102987A2 Methods and compositions based on protein interactions with mastermind
12/27/2002WO2002102986A2 Novel human transporter proteins and polynucleotides encoding the same
12/27/2002WO2002102984A2 Hdac9 polypeptides and polynucleotides and uses thereof
12/27/2002WO2002102979A2 Transformation of mono- and di- cotyledonous plants
12/27/2002WO2002102977A2 Characterization of a membrane estrogen receptor
12/27/2002WO2002102976A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002WO2002102975A2 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans
12/27/2002WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102970A2 Flax (linum usitatissimim l.) seed-specific promoters
12/27/2002WO2002102855A2 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
12/27/2002WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102853A2 Cd4-specific antibody trx1 and uses therefor
12/27/2002WO2002102852A2 Modified cd8 molecule, nucleic acid encoding said molecule, and their therapeut ic use
12/27/2002WO2002102848A2 Nucleic acid and amino acid sequences of a vegf variant
12/27/2002WO2002102847A1 Novel ligand and dna thereof
12/27/2002WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002WO2002102843A2 Gene expression during meningococcus adhesion
12/27/2002WO2002102841A2 Identification and cloning of the receptor gene for symbiotic nitrogen fixation
12/27/2002WO2002102840A2 Multiners of class i major histocompatibility complexes cantaining modified beta2-microglobulin proteins
12/27/2002WO2002102839A2 Novel g-protein coupled receptors and dna sequences thereof
12/27/2002WO2002102836A2 Moraxella (branhamella) catarrhalis antigens
12/27/2002WO2002102830A1 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
12/27/2002WO2002102828A2 Chimeric flavivirus vectors
12/27/2002WO2002102825A2 Fluorescently labelled locked nucleic acids
12/27/2002WO2002102824A2 Method for specific fast detection of relevant bacteria in drinking water
12/27/2002WO2002102820A1 Nucleoside derivatives for library preparation
12/27/2002WO2002102768A2 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways
12/27/2002WO2002102417A1 Vector and the use thereof in gene therapy methods
12/27/2002WO2002102411A2 Method for treating psoriasis by using an il-17d antagonist
12/27/2002WO2002102410A1 Subunit vaccines and processes for the production thereof
12/27/2002WO2002102404A1 Uses of cytokines
12/27/2002WO2002102321A2 Novel proteins and nucleic acids encoding same
12/27/2002WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma
12/27/2002WO2002102318A2 Eglin c based drugs for treatment of disease
12/27/2002WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002WO2002102306A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002WO2002102299A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
12/27/2002WO2002102235A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
12/27/2002WO2002102229A2 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002WO2002102144A1 Cell deah-inducible model nonhuman animal
12/27/2002WO2002102143A1 Transgenic animal transformed using green fluorescent protein gene
12/27/2002WO2002095036A3 A novel intein and uses thereof
12/27/2002WO2002095024A8 Method for constructing a chimeric dna library using a single strand specific dnase
12/27/2002WO2002092805A8 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tuberculosis
12/27/2002WO2002090533A9 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
12/27/2002WO2002086067A3 Mycobacterial sulfation pathway proteins and methods of use thereof
12/27/2002WO2002083909A3 Recombinant nucleotide sequence coding for a gene
12/27/2002WO2002081643A3 Methods for the preparation of polynucleotide librairies and identification of library members having desired characteristics
12/27/2002WO2002074071A3 Transgenic animal model of ige-mediated allergic responses
12/27/2002WO2002072864A3 Reagents for oligonucleotide cleavage and deprotection
12/27/2002WO2002072852A3 Leporipox-based vector vaccines
12/27/2002WO2002070662A3 Three hybrid assay system
12/27/2002WO2002070658A9 Compositions and methods for increasing amino acid absorption in mammals
12/27/2002WO2002066620A3 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system
12/27/2002WO2002064760A3 Expression of recombinant proteinase k from tritirachium album in yeast
12/27/2002WO2002062973A3 Lipase variants
12/27/2002WO2002057461A3 Regulation of human adam-ts-like zinc metalloprotease
12/27/2002WO2002057415A3 Method for altering cell fate
12/27/2002WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002WO2002056907A3 Molecular antigen array presenting amyloid beta
12/27/2002WO2002055720A9 Materials and methods relating to protein aggregation in neurodegenerative disease
12/27/2002WO2002052003A3 Regulation of human calcium channel
12/27/2002WO2002051994A3 Polypeptides
12/27/2002WO2002042452A3 Adapter protein and gene encoding it
12/27/2002WO2002040515A3 Exoenzyme toxin of aeromonas salmonicida, and uses thereof
12/27/2002WO2002040514A3 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
12/27/2002WO2002038733B1 A selectable genetic marker for use in pasteurellaceae species
12/27/2002WO2002029388A3 Fluorescence detection
12/27/2002WO2002029075A8 Multiple inducible gene regulation system
12/27/2002WO2002029065A3 Retroviral vectors containing internal ribosomal entry sites
12/27/2002WO2002029052A3 Regulation of human secretin receptor-like gpcr
12/27/2002WO2002026968A3 Antisense iap nucleic acids and uses thereof
12/27/2002WO2002026948A3 55054, a human metalloprotease and uses therefor
12/27/2002WO2002024908A9 Novel tissue-specific secretory polypeptide and dna thereof
12/27/2002WO2002024234A3 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
12/27/2002WO2002020800A3 16658, 14223, and 16002, NOVEL HUMAN KINASES AND USES THEREFOR
12/27/2002WO2002020755A3 Phenol oxidizing enzyme variants
12/27/2002WO2002016593A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/27/2002WO2002016396A3 Mammalian rh type b glycoprotein ion transporter
12/27/2002WO2002012467A3 Drug metabolizing enzymes
12/27/2002WO2002012279A3 Schizophrenia related gene and protein
12/27/2002WO2002010414A3 Expression of biologically active polypeptides in duckweed
12/27/2002WO2002010391A3 18610, a human transient receptor and uses thereof
12/27/2002WO2002010390A3 57250, a human sugar transporter family member and uses thereof
12/27/2002WO2002010379B1 Modified cea and uses thereof
12/27/2002WO2002008257A3 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
12/27/2002WO2002006500A3 Methods of transforming plants and identifying parental origin of a chromosome in those plants
12/27/2002WO2002004667A3 Improved detection signal and capture in dipstick assays
12/27/2002WO2002004623A3 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE
12/27/2002WO2002004514A8 Compositions and methods for the therapy and diagnosis of lung cancer
12/27/2002WO2002002754A3 Regulation of human alpha-hydroxysteroid dehydrogenase-like enzyme
12/27/2002WO2002000877A3 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis
12/27/2002WO2001096390A3 Compositions and methods for the therapy and diagnosis of colon cancer
1 ... 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 ... 4023